NCT07618507

Resistance Profile to Antiretroviral Medications in Individuals Living With HIV Who Failed a First-Line Regimen With Tenofovir / Lamivudina and Dolutegravir in Brasil

CompletedNAINTERVENTIONAL

Trial Details

Start: 2022-04-13Est. Completion: 2024-03-08

Enrollment target: 777 participants

Locations

Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Amazonas, Brazil
Centro Estadual Especializado em Diagnóstico, Assistência e Pesquisa (CEDAP), Salvador, Estado de Bahia, Brazil
Centro Especializado em Doenças Infecciosas (CEDIN-DF), Brasília, Federal District, Brazil
LADI - Laboratório de Apoio Diagnóstico em Infectologia (Hospital Universitário Miguel Riet Corrêa Jr), Porto Alegre, Rio Grande do Sul, Brazil
Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande do Sul, Brazil
Serviço Especializado em IST/HIV/AIDS Viamão, Viamão, Rio Grande do Sul, Brazil
Unidade de Infectologia William Rocha, Guarujá, São Paulo, Brazil
Retrovirology Laboratory - UNIFESP, São Paulo, São Paulo, Brazil
Hospital Santa Marcelina, São Paulo, São Paulo, Brazil

HIV InfectionsAdherence, Medication

The investigators will implement a 24-month fractional factorial design study (Aim 1). The investigators will recruit 51…

Cape Town, South AfricaEst. completion May 28, 2026

HIV-1-infection

The goal of this clinical study is to provide continued access to the study drug(s) to children and adolescents with hum…

Buenos Aires, ArgentinaEst. completion Mar 2034

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.